Funding for this research was provided by:
National Institutes of Health (HG007690,HL108630, HL155107, HL155096, and HL119145)
American Heart Association (D700382)
European Commission (848028≠2)
Swedish Cancer Society (CAN 2017/411)
Joanna Cocozza Foundation
National Research Foundation of Korea (NRF) grant funded by the Korea government (2021R1A2C101008211)
Austrian Science Funds (P32953, I4437)
Received: 21 December 2021
Accepted: 13 April 2022
First Online: 6 May 2022
: The human studies were approved by the Linköping University Hospital Institutional Review Board and Medical University of Vienna. Written informed consent was obtained from all participants to participate in the study. This study was conducted in accordance with the Declaration of Helsinki.
: Not appliable
: MB is scientific founder of Mavatar, Inc. JL is co-scientific founder of Scipher Medicine, Inc. The other authors declare that they have no competing interests.